Hypersensitivity Reaction to High-Dose Methotrexate and Successful Rechallenge in a Pediatric Patient With Osteosarcoma

Pediatric Blood and Cancer - United States
doi 10.1002/pbc.24741
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Carboxypeptidase-G2 Rescue in a Patient With High Dose Methotrexate-Induced Nephrotoxicity

Cancer Research and Treatment
Cancer ResearchOncology
2005English

Safety and Efficacy of High-Dose Methotrexate for Osteosarcoma in Adolescents Compared With Young Adults

Cancer Medicine
Cancer ResearchNuclear MedicineRadiologyImagingOncology
2018English

Efficacy of High Dose Methotrexate in Pediatric Auto-Immune Uveitis

Pediatric Rheumatology
ImmunologyPediatricsRheumatologyAllergyPerinatologyChild Health
2014English

Successful Rechallenge With Reduced Dose of Erlotinib in a Patient With Lung Adenocarcinoma Who Developed Erlotinib‑associated Leukocytoclastic Vasculitis: A Case Report

Oncology Letters
Cancer ResearchOncology
2012English

Successful Desensitization to Irinotecan After Severe Hypersensitivity Reaction

Journal of Investigational Allergology and Clinical Immunology
AllergyImmunology
2016English

Ifosfamide/Etoposide Alternating With High-Dose Methotrexate: Evaluation of a Chemotherapy Regimen for Poor-Risk Osteosarcoma

British Journal of Cancer
Cancer ResearchOncology
1999English

Cytomegalovirus Pneumonia in a Patient With Rheumatoid Arthritis Treated With Low Dose Methotrexate and Prednisone.

Annals of the Rheumatic Diseases
ImmunologyMolecular BiologyBiochemistryRheumatologyAllergyGenetics
1991English

Hispanic Ethnicity as a Risk Factor for Requiring Glucarpidase Rescue in Pediatric Patients Receiving High-Dose Methotrexate

American Journal of Hematology
Hematology
2017English

Rituximab Hypersensitivity in IgG4-related Disease: Successful Desensitization in a Patient With IgG4 Rheumatoid Factor

International Journal of Rheumatic Diseases
Rheumatology
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy